Cochrane · systematic review · CD009289
Topical azole treatments for otomycosis
Lee, A, Tysome, JR, Saeed, SR · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 75%Low 1 · 25%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Clotrimazole compared to another azole for otomycosis
Population: patients with otomycosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Complete clinical resolution Clotrimazole vs another azole | RR 0.8 [0.59, 1.07] | 3 studies · 439 participants | Very low Downgraded: risk of bias, inconsistency |
Significant adverse events Clotrimazole vs another azole | no estimate extracted | 1 study · 174 participants | Very low Downgraded: imprecision |
Mycological resolution Clotrimazole vs another azole | RR 1.01 [0.96, 1.06] | 1 study · 174 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness |
Other adverse events Clotrimazole vs another azole | RR 0.79 [0.18, 3.41] | 1 study · 174 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness |